HealthEquity, Inc. $HQY Shares Bought by 12th Street Asset Management Company LLC

12th Street Asset Management Company LLC grew its position in shares of HealthEquity, Inc. (NASDAQ:HQY) by 114.4% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 272,068 shares of the company’s stock after purchasing an additional 145,151 shares during the quarter. HealthEquity makes up about 4.4% of 12th Street Asset Management Company LLC’s holdings, making the stock its 10th largest position. 12th Street Asset Management Company LLC owned 0.32% of HealthEquity worth $25,784,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in the company. Westfield Capital Management Co. LP grew its stake in HealthEquity by 124.6% during the 2nd quarter. Westfield Capital Management Co. LP now owns 1,265,208 shares of the company’s stock worth $132,543,000 after buying an additional 701,819 shares during the last quarter. Charles Schwab Investment Management Inc. grew its position in shares of HealthEquity by 2.6% during the second quarter. Charles Schwab Investment Management Inc. now owns 1,129,115 shares of the company’s stock worth $118,286,000 after acquiring an additional 28,145 shares during the last quarter. Geneva Capital Management LLC grew its position in shares of HealthEquity by 6.2% during the second quarter. Geneva Capital Management LLC now owns 1,108,241 shares of the company’s stock worth $116,099,000 after acquiring an additional 64,487 shares during the last quarter. AQR Capital Management LLC increased its holdings in shares of HealthEquity by 148.5% in the 2nd quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company’s stock valued at $116,016,000 after acquiring an additional 661,795 shares during the period. Finally, JPMorgan Chase & Co. raised its position in HealthEquity by 19.5% in the 2nd quarter. JPMorgan Chase & Co. now owns 1,080,794 shares of the company’s stock valued at $113,224,000 after purchasing an additional 176,435 shares during the last quarter. 99.55% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research analysts have commented on HQY shares. BMO Capital Markets restated a “market perform” rating on shares of HealthEquity in a research note on Thursday, December 4th. Citigroup reiterated an “outperform” rating on shares of HealthEquity in a research note on Thursday, December 4th. JMP Securities set a $122.00 price target on HealthEquity in a research report on Thursday, December 4th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of HealthEquity in a research note on Thursday, January 22nd. Finally, Deutsche Bank Aktiengesellschaft reiterated a “buy” rating and issued a $120.00 target price on shares of HealthEquity in a research note on Friday, December 5th. Two analysts have rated the stock with a Strong Buy rating, twelve have issued a Buy rating, two have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, HealthEquity presently has an average rating of “Moderate Buy” and an average price target of $119.60.

Insiders Place Their Bets

In other HealthEquity news, EVP Elimelech Rosner sold 10,959 shares of the stock in a transaction on Thursday, December 18th. The stock was sold at an average price of $95.45, for a total transaction of $1,046,036.55. Following the sale, the executive vice president owned 45,742 shares in the company, valued at approximately $4,366,073.90. This represents a 19.33% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Delano Ladd sold 1,500 shares of the company’s stock in a transaction on Friday, December 19th. The shares were sold at an average price of $94.72, for a total value of $142,080.00. Following the completion of the sale, the executive vice president owned 73,979 shares in the company, valued at $7,007,290.88. This represents a 1.99% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last quarter, insiders have sold 13,959 shares of company stock worth $1,344,957. 1.50% of the stock is owned by insiders.

HealthEquity Stock Down 4.8%

HealthEquity stock opened at $73.21 on Friday. HealthEquity, Inc. has a fifty-two week low of $72.99 and a fifty-two week high of $116.65. The firm has a market capitalization of $6.26 billion, a price-to-earnings ratio of 33.58, a price-to-earnings-growth ratio of 0.96 and a beta of 0.24. The stock’s fifty day moving average is $88.81 and its two-hundred day moving average is $92.45. The company has a debt-to-equity ratio of 0.46, a quick ratio of 4.13 and a current ratio of 4.13.

HealthEquity (NASDAQ:HQY) last issued its quarterly earnings data on Wednesday, December 3rd. The company reported $1.01 EPS for the quarter, beating analysts’ consensus estimates of $0.90 by $0.11. The firm had revenue of $322.16 million for the quarter, compared to analysts’ expectations of $320.92 million. HealthEquity had a net margin of 14.86% and a return on equity of 12.94%. The firm’s revenue was up 7.2% on a year-over-year basis. During the same period in the prior year, the company earned $0.78 EPS. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. Analysts predict that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.